Five Beaten-Up Biotech Stocks Saw Big Share Purchases

Text size
Biotech stocks have taken some lumps this year, and some have seen some large stock purchases made by big shareholders. Shares of cancer-therapy developers
Kymera Therapeutics
(ticker: KYMR),
Cullinan Oncology
(CGEM), and
Repare Therapeutics
(RPTX) are down 77%, 22%, and 35%, respectively, so far this year. Kymera’s first-quarter report and a business update sent shares tumbling in early May. Cullinan stock has been on a steady decline since November.

Read the source article at News Brig
2022-06-13 01:16:04